Back
Xeris Biopharma Holdings Quote, Financials, Valuation and Earnings
Buy
89
XERS
Xeris Biopharma Holdings
Last Price:
1.98
Seasonality Move:
-12.45%
7 Day Trial
ALL ACCESS PASS
$
7
Xeris Biopharma Holdings Price Quote
$1.98
Xeris Biopharma Holdings Key Stats
Buy
89
Xeris Biopharma Holdings (XERS)
is a Buy
Day range:
$1.96 - $2.07
52-week range:
$1.46 - $3.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.48
P/B ratio:
0%
Volume:
1.2M
Avg. volume:
1.4M
1-year change:
-29.29%
Market cap:
$260.9M
Revenue:
$163.9M
EPS:
$-0.44
How Much Does Xeris Biopharma Holdings Make?
-
How Much Are Xeris Biopharma Holdings's Sales Annually?
XERS Revenues are $163.9M -
How Much Profit Does Xeris Biopharma Holdings's Make A Year?
XERS net income is -$62.3M
Is Xeris Biopharma Holdings Growing As A Company?
-
What Is Xeris Biopharma Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Xeris Biopharma Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Xeris Biopharma Holdings Stock Price Performance
-
Did Xeris Biopharma Holdings Stock Go Up Last Month?
Xeris Biopharma Holdings share price went up by 11.24% last month -
Did XERS's Share Price Rise Over The Last Year?
XERS share price fell by -29.29% over the past 1 year
What Is Xeris Biopharma Holdings 52-Week High & Low?
-
What Is Xeris Biopharma Holdings’s 52-Week High Share Price?
Xeris Biopharma Holdings has traded as high as $3.26 over the past 52 weeks -
What Is Xeris Biopharma Holdings’s 52-Week Low Share Price?
Xeris Biopharma Holdings has traded as low as $1.46 over the past 52 weeks
Xeris Biopharma Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Xeris Biopharma Holdings?
-
How Much Debt Does Xeris Biopharma Holdings Have?
Total long term debt quarterly is $190.9M -
How Much Cash Does Xeris Biopharma Holdings Have?
Cash and short term investments quarterly total is $72.5M -
What Is Xeris Biopharma Holdings’s Book Value Per Share?
Book value per share is -0.05
Is Xeris Biopharma Holdings Cash Flow Positive?
-
What Is XERS Cash Flow From Operations?
Cash flow from operations (TTM) is -$47M -
What Is Xeris Biopharma Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.6M -
What Is Xeris Biopharma Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6M
Xeris Biopharma Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
XERS return on invested capital is -30.22% -
What Is Xeris Biopharma Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -18.92% -
What Is XERS Return On Equity?
ROE is a measure of profitability and is -362.12%
Xeris Biopharma Holdings Earnings Date & Stock Price
-
What Is Xeris Biopharma Holdings's Stock Price Today?
A single share of XERS can be purchased today for 1.98 -
What Is Xeris Biopharma Holdings’s Stock Symbol?
Xeris Biopharma Holdings trades on the nasdaq under the ticker symbol: XERS -
When Is Xeris Biopharma Holdings’s Next Earnings Date?
The next quarterly earnings date for Xeris Biopharma Holdings is scheduled on August 8, 2024 -
When Is XERS's next ex-dividend date?
Xeris Biopharma Holdings's next ex-dividend date is May 18, 2024 -
How To Buy Xeris Biopharma Holdings Stock?
You can buy Xeris Biopharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Xeris Biopharma Holdings Competitors
-
Who Are Xeris Biopharma Holdings's Competitors?
Below is a list of companies who compete with Xeris Biopharma Holdings or are related in some way:
Xeris Biopharma Holdings Dividend Yield
Data Unavailable
Xeris Biopharma Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -32.08% |
Revenue: | 33.93% | -2.81% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 4.90 |
Upside from Last Price: | 147.47% |